Science and Engineering Summit for Undergraduates at D. E. Shaw Research

D. E. Shaw Research
Science and Engineering Summit for Undergraduates
Friday, April 3, 2020

D. E. Shaw Research (DESRES) seeks exceptional undergraduates pursuing degrees in the computational sciences to join us at our Science and Engineering Summit for Undergraduates.  This event will take place on Friday, April 3, 2030, and will bring students pursuing bachelor’s degrees in science and engineering to our offices in New York City for a day of presentations, discussions, networking, and plenty of refreshments!  This is an opportunity to learn about the internship and career opportunities available at DESRES, explore our scientific computing and research projects in detail, and connect with other students from across the country who share your interest in science and technology.

Enjoy the vantage point from our Times Square office and an evening in New York City on us!  We will cover the cost of travel to and from New York as well as hotel accommodations for two nights for all selected attendees.

If you are studying computer science, engineering, biology, chemistry, physics, applied math, materials science, or another scientific field with a focus on computational methods, and are interested in attending this event, please email your resume and a short statement of interest (approx. 200 words) to DESRESSummit@DEShawResearch.com with the subject line “2020 Summit Application” by Tuesday, February 18, 2020.  We can only invite a limited number of attendees to the summit, but we welcome submissions from students of all experience levels.

D. E. Shaw Research is a New York–based independent research laboratory that conducts basic scientific research in the field of computational biochemistry under the direct scientific leadership of Dr. David Shaw. Our group is currently focusing primarily on long molecular dynamics simulations involving proteins and other biological macromolecules of potential interest from both a scientific and a pharmaceutical perspective. An integral part of our effort consists of designing and developing custom hardware and software to carry out this research. We are also pursuing drug discovery programs, leveraging the insights enabled by our novel technologies, with an initial focus on drug targets that have proved resistant to traditional drug discovery methods. For more information about the group, please visit www.DEShawResearch.com.